Gastrointestinal stromal tumors express the orexigen ghrelin
2006 (English)In: Endocrine-Related Cancer, ISSN 1351-0088, Vol. 13, no 3, 963-970 p.Article in journal (Refereed) Published
Expression of the neuroendocrine marker synaptic vesicle protein 2 (SV2) has been reported in a few cases of gastrointestinal stromal tumors (GISTs). The goal of the present study was to assess the relevance of this finding and identify a possible hormone production in these tumors. We chose to study the orexigen ghrelin and its receptor, since these patients are seldom cachexic, even in advanced disease stages. We investigated ghrelin expression by means of immunohistochemistry on frozen or paraffin-embedded sections from 22 GISTs from a well-characterized patient material. Expression of the growth hormone secretagogue receptor, the ghrelin receptor, was investigated in a subset of lesions. In six tumors, mRNA levels of ghrelin, the ghrelin receptor, and SV2 were analyzed by real-time quantitative PCR. Totally 17 out of 22 tumors showed immunoreactivity for ghrelin. Five out of ten tumors were immunoreactive for the ghrelin receptor, and all of these co-expressed ghrelin. All tumors expressed ghrelin, ghrelin receptor, and SV2 mRNA. GISTs frequently express SV2, ghrelin, and its receptor, indicating the presence of autocrine/paracrine loops.
Place, publisher, year, edition, pages
2006. Vol. 13, no 3, 963-970 p.
gastrointestinal stromal tumors, neuroendocrine
Cancer and Oncology
IdentifiersURN: urn:nbn:se:uu:diva-83733DOI: 10.1677/erc.1.01201ISI: 000241924200022PubMedID: 16954444OAI: oai:DiVA.org:uu-83733DiVA: diva2:111641